Cover Image
Market Research Report
Product code 
1085866

Therapeutic Proteins and Oral Vaccines Market, by Drug Class (Therapeutic Proteins and Oral Vaccines, by Application, by Distribution Channel Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published: | Coherent Market Insights | 327 Pages | Delivery time: 2-3 business days

Price

Back to Top
Therapeutic Proteins and Oral Vaccines Market, by Drug Class (Therapeutic Proteins and Oral Vaccines, by Application, by Distribution Channel Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Published: May 31, 2022
Coherent Market Insights
Content info: 327 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

Oral administration of vaccines is the most convenient way of vaccination, owing to the factors such as oral vaccines are non-invasive, safe, and suitable for all age groups, especially children. Oral vaccines are mostly preferred for mass vaccination and are mostly liquid filled in sachet or blister. Oral vaccines are commonly available for diseases such as typhoid, cholera, adenovirus, rotavirus, and others.

Therapeutic proteins can be used to replace a protein that is abnormal or deficient in a particular disease. They can also augment the body's supply of a beneficial protein to help reduce the impact of disease or chemotherapy. Genetically engineered proteins can closely resemble the natural proteins they replace, or they can be enhanced by adding sugars or other molecules that extend the protein's duration of therapeutic activity in patients.

Market Dynamics

Key companies focusing on product approvals of oral vaccines and therapeutic proteins, is expected to drive the global therapeutic proteins and oral vaccines market. For instance, in July 2018, Emergent BioSolutions Inc. announced that it received marketing authorization from European Medicine Agency for its oral typhoid vaccine Vivotif (Typhoid Vaccine Live Oral Ty21a) in five European countries such as France, Portugal, Poland, Czech Republic, and Slovakia. Moreover, in May 2018, Amgen Inc. received the U.S. Food and Drug Administration approval for Aimovig (erenumab-aooe), indicated for preventive treatment of migraine in adults.

Key features of the study:

  • This report provides in-depth analysis of the global therapeutic proteins and oral vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
  • It profiles leading players in the global therapeutic proteins and oral vaccines based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global therapeutic proteins and oral vaccines market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision-making through various strategy matrices used in analyzing the global therapeutic proteins and oral vaccines market

Detailed Segmentation:

  • Global Therapeutic Proteins and Oral Vaccine Market, By Drug Class :
    • Therapeutic Proteins
      • Growth Factors
      • Fusion Proteins
      • Monoclonal Antibodies
      • Hormones
      • Coagulation Factors
      • Others
    • Oral Vaccines
      • Live Attenuated Vaccine
      • Inactivated Vaccine
      • Recombinant Vaccine
      • Others
  • Global Therapeutic Proteins and Oral Vaccine Market, By Application :
    • Oncology
    • Hematology
    • Immunology
    • Endocrinology
    • Infectious Disease
    • Cardiovascular Disease
    • Others
  • Global Therapeutic Proteins and Oral Vaccine Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Therapeutic Proteins and Oral Vaccine Market, By Region:
    • North America
      • By Drug Class:
      • Therapeutic Proteins
      • Growth Factors
      • Fusion Proteins
      • Monoclonal Antibodies
      • Hormones
      • Coagulation Factors
      • Others
      • Oral Vaccines
      • Live Attenuated Vaccine
      • Inactivated Vaccine
      • Recombinant Vaccine
      • Others
      • By Application :
      • Oncology
      • Hematology
      • Immunology
      • Endocrinology
      • Infectious Disease
      • Cardiovascular Disease
      • Others
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Drug Class:
      • Therapeutic Proteins
      • Growth Factors
      • Fusion Proteins
      • Monoclonal Antibodies
      • Hormones
      • Coagulation Factors
      • Others
      • Oral Vaccines
      • Live Attenuated Vaccine
      • Inactivated Vaccine
      • Recombinant Vaccine
      • Others
      • By Application :
      • Oncology
      • Hematology
      • Immunology
      • Endocrinology
      • Infectious Disease
      • Cardiovascular Disease
      • Others
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Drug Class:
      • Therapeutic Proteins
      • Growth Factors
      • Fusion Proteins
      • Monoclonal Antibodies
      • Hormones
      • Coagulation Factors
      • Others
      • Oral Vaccines
      • Live Attenuated Vaccine
      • Inactivated Vaccine
      • Recombinant Vaccine
      • Others
      • By Application :
      • Oncology
      • Hematology
      • Immunology
      • Endocrinology
      • Infectious Disease
      • Cardiovascular Disease
      • Others
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Drug Class:
      • Therapeutic Proteins
      • Growth Factors
      • Fusion Proteins
      • Monoclonal Antibodies
      • Hormones
      • Coagulation Factors
      • Others
      • Oral Vaccines
      • Live Attenuated Vaccine
      • Inactivated Vaccine
      • Recombinant Vaccine
      • Others
      • By Application :
      • Oncology
      • Hematology
      • Immunology
      • Endocrinology
      • Infectious Disease
      • Cardiovascular Disease
      • Others
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Drug Class:
      • Therapeutic Proteins
      • Growth Factors
      • Fusion Proteins
      • Monoclonal Antibodies
      • Hormones
      • Coagulation Factors
      • Others
      • Oral Vaccines
      • Live Attenuated Vaccine
      • Inactivated Vaccine
      • Recombinant Vaccine
      • Others
      • By Application :
      • Oncology
      • Hematology
      • Immunology
      • Endocrinology
      • Infectious Disease
      • Cardiovascular Disease
      • Others
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Drug Class:
      • Therapeutic Proteins
      • Growth Factors
      • Fusion Proteins
      • Monoclonal Antibodies
      • Hormones
      • Coagulation Factors
      • Others
      • Oral Vaccines
      • Live Attenuated Vaccine
      • Inactivated Vaccine
      • Recombinant Vaccine
      • Others
      • By Application :
      • Oncology
      • Hematology
      • Immunology
      • Endocrinology
      • Infectious Disease
      • Cardiovascular Disease
      • Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Abbott Laboratories.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Amgen, Inc.
    • Biogen, Inc.
    • Eily, Lilly, and Company
    • F. Hoffmann-La Roche
    • Johnson and Johnson
    • Merck & Co.
    • Novo Nordisk
    • Pfizer, Inc.
    • Sanofi S.A.
    • Serum Institute of India Pvt. Ltd.
    • Emergent Biosolutions Inc.
    • TransAlgae
    • MigVax Ltd
    • Lumen Bioscience, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI4396

Table of Contents

  • Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
  • Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Class
  • Market Snippet, By Application
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)
  • Market Dynamics, Regulations, and Trends Analysis
  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Epidemiology
  • Product Approvals
  • Product Launches
  • Mergers and Acquisitions
  • Pipeline Analysis
  • Regulatory Scenario
  • Reimbursement Scenario
  • Pest Analysis
  • Pricing Analysis & Major Brand Analysis
  • Treatment Algorithm
  • Competitive Intelligence
  • Manufacturing Technologies
  • Biosimilar Overview
  • Global Therapeutic Proteins and Oral Vaccines Market, Impact of COVID-19 Pandemic
  • Post COVID-19 Impact on Manufacturing
  • Impact on Research and Development
  • Global Therapeutic Proteins and Oral Vaccines Market, By Drug Class, 2017 - 2028 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Segment Trends
  • Therapeutic Proteins
  • Growth Factors
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Fusion Proteins
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Monoclonal Antibodies
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Hormones
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Coagulation Factors
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Oral Vaccines
  • Live Attenuated Vaccine
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Inactivated Vaccine
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Recombinant Vaccine
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market size and forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Global Therapeutic Proteins and Oral Vaccines Market, By Application, 2017 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Infectious Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Cardiovascular Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Global Therapeutic Proteins and Oral Vaccines Market, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
    • Polymerase Chain Reaction ( PVR)
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Global Therapeutic Proteins and Oral Vaccines Market, By Region, 2017 - 2028 (US$ Mn)
  • Introduction
  • Market Share Analysis, By Country, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017 - 2028
  • North America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa
  • Competitive Landscape
  • Company Profiles
  • Abbott Laboratories
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Amgen, Inc.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Biogen, Inc.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Eily, Lilly, and Company
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • F. Hoffmann-La Roche
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Johnson and Johnson
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Merck & Co.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Novo Nordisk
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Pfizer, Inc.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Sanofi S.A.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Emergent Biosolutions Inc.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • TransAlgae
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • MigVax Ltd
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Lumen Bioscience, Inc.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies